Showing results (71-80 of 103) with videos related to
Sort By:
Pageof 11
European Journal of Cancer (Oxford, England : 1990)|August 1, 1997
Phase II study of weekly 4'-epidoxorubicin in patients with metastatic adenocarcinoma of the cervix: an EORTC Gynaecological Cancer Cooperative Group studyM E van der Burg, G Bolis, P J Bakker, et al.International Journal of Cancer|October 23, 1997
Generation and phenotypic characterization of new human ovarian cancer cell lines with the identification of antigens potentially recognizable by HLA-restricted cytotoxic T cellsV Ramakrishna, D R Negri, V Brusic, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 21, 1998
Topotecan for the treatment of advanced epithelial ovarian cancer: an open-label phase II study in patients treated after prior chemotherapy that contained cisplatin or carboplatin and paclitaxelM A Bookman, H Malmström, G Bolis, et al.Regulatory Peptides|April 29, 1998
Chromatographic and immunological identification of GnRH (gonadotropin-releasing hormone) variants. Occurrence of mammalian and a salmon-like GnRH in the forebrain of an eutherian mammal: Hydrochaeris hydrochaeris (Mammalia, Rodentia)A D Montaner, G M Somoza, J A King, et al.The Journal of Clinical Endocrinology and Metabolism|November 29, 2013
Vitamin D protects human endothelial cells from oxidative stress through the autophagic and survival pathwaysF Uberti, D Lattuada, V Morsanuto, et al.Journal of Hematotherapy|October 1, 1995
Bispecific antibody targeted T cell therapy of ovarian cancer: clinical results and future directionsS Canevari, D Mezzanzanica, A Mazzoni, et al.Gynecologic Oncology|July 6, 2010
Is adjuvant chemotherapy indicated in stage I pure immature ovarian teratoma (IT)? A multicentre Italian trial in ovarian cancer (MITO-9)G Mangili, G Scarfone, A Gadducci, et al.Journal of Medicinal Chemistry|October 28, 1997
Phenylimidazolidin-2-one derivatives as selective 5-HT3 receptor antagonists and refinement of the pharmacophore model for 5-HT3 receptor bindingF Heidempergher, A Pillan, V Pinciroli, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 1, 1997
Experience with independent radiological review during a topotecan trial in ovarian cancerS Gwyther, G Bolis, M Gore, et al.Journal of the National Cancer Institute|October 4, 1989
Randomized trial in advanced ovarian cancer comparing cisplatin and carboplatinC Mangioni, G Bolis, S Pecorelli, et al.Pageof 11